Noble Pharmacy Inc
Pharmacy
321 E Alameda Blvd, Suite L, Burbank
California, 91502-3328
818-563-6655 818-563-6611
Noble Pharmacy Inc is an authorized DME supplier for medicare equipments and products.
Noble Pharmacy Inc is a Pharmacy in Burbank, California. It is located at 321 E Alameda Blvd, Suite L, Burbank and it's customer support contact number is 818-563-6655. The authorized person of Noble Pharmacy Inc is Edwin Bedrosian who is Ceo of the pharmacy and his contact number is 818-321-0177. Active license number of Noble Pharmacy Inc is PHY 44636 for Pharmacy in California. Noble Pharmacy Inc accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance.
Noble Pharmacy Inc is a facility used by pharmacists for the compounding and dispensing of medicinal preparations and other associated professional and administrative services. A pharmacy is a facility whose primary function is to store, prepare and legally dispense prescription drugs under the professional supervision of a licensed pharmacist. It meets any licensing or certification standards set forth by the jurisdiction where it is located.
Pharmacy Details:
Noble Pharmacy Inc type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
| Name: | Noble Pharmacy Inc |
| Type: | Pharmacy |
| Location: | 321 E Alameda Blvd, Suite L, Burbank, California, 91502-3328 |
| Phone: | 818-563-6655 |
| Fax: | 818-563-6611 |
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
| Name: | Edwin Bedrosian |
| Position: | Ceo |
| Contact Number: | 818-321-0177 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
| NPI Number: | 1336130186 |
| NPI Enumeration Date: | 01 Nov, 2005 |
| NPI Last Update On: | 15 Mar, 2022 |
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Noble Pharmacy Inc are as mentioned below.
| Specialization | License Number | State | Status | |
| Pharmacy | PHY 44636 | California | Primary | |
| Durable Medical Equipment & Medical Supplies | | | Secondary | |
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
| Identifier | Type | State | Issuer |
| 1336130186 | Medicaid | California | |
Medicare Enrollment:
Noble Pharmacy Inc is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
| PAC ID: |
Enrollment ID: |
Org Name | Medicare Entity Type |
| 2961523055 | O20100930100570 | Noble Pharmacy Inc | DME SUPPLIER - PHARMACY |
Products Available:
Noble Pharmacy Inc has following products available for sale under medicare.
| Products: |
|---|
| • Blood Glucose Monitors & Supplies: Non-mail Order | |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 321 E Alameda Blvd, Suite L Burbank, California |
| Zip: | 91502-3328 |
| Phone Number: | 818-563-6655 |
| Fax Number: | 818-563-6611 |
Patients can reach Noble Pharmacy Inc at
321 E Alameda Blvd, Suite L, Burbank, California or can
call on customer care at 818-563-6655.
Comments/ Reviews:
Read all the reviews posted for Noble Pharmacy Inc below. You may also share your own experience with Noble Pharmacy Inc. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.